20348-16-7

Basic information

• Product Name: 2-amino-6-methylpyridin-3-ol
• Synonyms: 2-amino-6-methylpyridin-3-ol;2-Amino-3-Hydroxy-6-Picoline;2-Amino-3-hydroxy-6-methylpyridine;Einecs 243-752-7
• CAS NO: 20348-16-7
• Molecular Formula: C₆H₈N₂O
• Molecular Weight: 124.14052
• EINECS: 243-752-7
• Product Categories: Pyridine
• Mol File: 20348-16-7.mol
• Article Data: 30

Chemical Properties

• Boiling Point: 342.7 °C at 760 mmHg
• Flash Point: 161.1 °C
• Appearance: /
• Density: 1.245 g/cm³
• Vapor Pressure: 3.72E-05mmHg at 25°C
• Refractive Index: 1.626
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: 2-amino-6-methylpyridin-3-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-amino-6-methylpyridin-3-ol(20348-16-7)
• EPA Substance Registry System: 2-amino-6-methylpyridin-3-ol(20348-16-7)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 20348-16-7(Hazardous Substances Data)

Usage

General Description

2-amino-6-methylpyridin-3-ol is a chemical compound with the molecular formula C6H8N2O. It is a derivative of pyridine and contains an amino group and a hydroxyl group. 2-amino-6-methylpyridin-3-ol has potential applications in the pharmaceutical industry, particularly in the development of drugs for treating diseases such as cancer, inflammation, and neurodegenerative disorders. It may also be used as a building block in the synthesis of other organic compounds. The chemical properties and reactivity of 2-amino-6-methylpyridin-3-ol make it a valuable and versatile molecule in various research and industrial applications.

InChI:InChI=1/C6H8N2O/c1-4-2-3-5(9)6(7)8-4/h2-3,9H,1H3,(H2,7,8)

Upstream product

• 1121-78-4 5-Hydroxy-2-methylpyridine 
• 15128-90-2 6-methyl-2-nitropyridin-3-ol 

Downstream Products

• 81066-67-3 2-amino-3-(phenylmethoxy)-6-methylpyridine 
• 55656-32-1 5-Methyl-3H-oxazolo<4,5-b>pyridine-2-thione 
• 134377-98-3 2-(2-fluorophenyl)-5-methyloxazolo[4,5-b]pyridine 
• 20348-10-1 6-methyl-2H-pyrido[3,2-b]-1,4-oxazin-3(4h)-one 
• 134337-07-8 5-methyl-3-<2-(4-phenyl-1-piperazinyl)ethyl>oxazolo<4,5-b>pyridin-2(3H)-one 
• 55656-25-2 5-METHYL-3H-OXAZOLO[4,5-b]-PYRIDIN-2-ONE 
• 1134198-37-0 2-({1-[trans-4-(ethyloxy)-1-methylcyclohexyl]-4-piperidinyl}amino)-6-methyl-3-pyridinol 
• 1355026-63-9 C₁₄H₁₀Cl₂N₂O₂ 
• 1355026-42-4 C₁₄H₁₄Cl₂N₂O₂ 
• 1564284-01-0 5-methyl-N-(4-(trifluoromethyl)phenyl)oxazolo[4,5-b]pyridin-2-amine 
• 1564284-07-6 N-cyclohexyl-5-methyloxazolo[4,5-b]pyridin-2-amine 
• 1564283-89-1 5-methyl-N-phenyloxazolo[4,5-b]pyridin-2-amine 
• 1564283-91-5 N-(4-fluorophenyl)-5-methyloxazolo[4,5-b]pyridin-2-amine 
• 1564283-93-7 N-(4-chlorophenyl)-5-methyloxazolo[4,5-b]pyridin-2-amine 

Relevant articles and documents

Targeting cyclic nucleotide phosphodiesterase 5 (PDE5) in brain: Toward the development of a PET radioligand labeled with fluorine-18

With the aim to develop a specific radioligand for imaging the cyclic nucleotide phosphodiesterase 5 (PDE5) in brain by positron emission tomography (PET), seven new fluorinated inhibitors (3–9) were synthesized on the basis of a quinoline core. The inhibitory activity for PDE5 together with a panel of other PDEs was determined in vitro and two derivatives were selected for IC50 value determination. The most promising compound 7 (IC50 = 5.92 nM for PDE5A), containing a 3-fluoroazetidine moiety, was further radiolabeled by aliphatic nucleophilic substitution of two different leaving groups (nosylate and tosylate) using [18F]fluoride. The use of the nosylate precursor and tetra-n-butyl ammonium [18F]fluoride ([18F]TBAF) in 3-methyl-3-pentanol combined with the addition of a small amount of water proved to be the best radiolabeling conditions achieving a RCY of 4.9 ± 1.5% in an automated procedure. Preliminary biological investigations in vitro and in vivo were performed to characterize this new PDE5 radioligand. Metabolism studies of [18F]7 in mice revealed a fast metabolic degradation with the formation of radiometabolites which have been detected in the brain.

HARMFUL ARTHROPOD CONTROL COMPOSITION, AND FUSED HETEROCYCLIC COMPOUND

Disclosed is a harmful arthropod control composition comprising, as an active ingredient, a fused heterocyclic compound represented by formula (1) [wherein A1 and A2 independently represent a nitrogen atom or the like; R1 and R4 independently represent a halogen atom or the like; R2 and R3 independently represent a halogen atom or the like; R5 and R6 independently represent a linear C1-C6 hydrocarbon group which may be substituted, or the like (provided that both R5 and R6 cannot represent a hydrogen atom simultaneously); and n represents 0 or 1]. The harmful arthropod control composition has an excellent efficacy to control harmful arthropods.

COMPOSITION AND METHOD FOR CONTROLLING ARTHROPOD PESTS

The present invention provides: an arthropod pests control composition comprising, as active ingredients, a condensed heterocyclic compound and a neonicotinoid compound; a method for controlling arthropod pests which comprises applying effective amounts of a condensed heterocyclic compound and a neonicotinoid compound to the arthropod pests or a locus where the arthropod pests inhabit; and so on.